Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Treatment for Persisting Pregnancy of Unknown Location (PPUL)
NCT01800162Phase 2Terminated
- Sponsor
- University of Pennsylvania
- Start
- Feb 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in Pregnancy of unknown location (PUL), Ectopic pregnancy (EP), sponsored by University of Pennsylvania. Started Feb 2013; status: terminated.
02
Drugs
methotrexate
03
Conditions
Pregnancy of unknown location (PUL)Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT01800162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800162.